Delayed-release dimethyl fumarate demonstrated no evidence of difference in clinical outcomes vs fingolimod in patients with RRMS: a propensity-matched comparative effectiveness analysis of the German NeuroTransData registry
2015 ◽
Vol 37
(1)
◽
pp. 134-144
◽
2019 ◽
Vol 7
◽
pp. 85-86